Literature DB >> 30606696

Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF).

Sara Montagnese1, Francesco Paolo Russo2, Piero Amodio3, Patrizia Burra2, Antonio Gasbarrini4, Carmela Loguercio5, Giulio Marchesini6, Manuela Merli7, Francesca Romana Ponziani4, Oliviero Riggio7, Carmelo Scarpignato8.   

Abstract

Hepatic encephalopathy (HE) is a common, worrisome and sometimes difficult to manage complication of end-stage liver disease. HE is often recurrent, requiring multiple hospital admissions. It can have serious implications in terms of a patient's ability to perform complex tasks (for example driving), their earning capacity, their social and family roles. This guideline reviews current knowledge on HE definition, pathophysiology, diagnosis and treatment, both by general principles and by way of a summary of available drugs and treatment strategies. The quality of the published, pertinent evidence is graded, and practical recommendations are made. Where possible, these are placed within the Italian health service context, with reference to local diagnosis and management experience.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AISF; Guideline; Hepatic encephalopathy

Mesh:

Year:  2018        PMID: 30606696     DOI: 10.1016/j.dld.2018.11.035

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  17 in total

1.  Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model.

Authors:  Heba M A Khalil; Islam A Khalil; Asmaa K Al-Mokaddem; Marwa Hassan; Riham A El-Shiekh; Hesham A Eliwa; Azza M Tawfek; Walaa H El-Maadawy
Journal:  Drug Deliv Transl Res       Date:  2022-06-07       Impact factor: 4.617

Review 2.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

Review 3.  Clinical management of type C hepatic encephalopathy.

Authors:  Lorenzo Ridola; Oliviero Riggio; Stefania Gioia; Jessica Faccioli; Silvia Nardelli
Journal:  United European Gastroenterol J       Date:  2020-02-26       Impact factor: 4.623

4.  Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization.

Authors:  Zhaohui Bai; Xiaozhong Guo; Frank Tacke; Yingying Li; Hongyu Li; Xingshun Qi
Journal:  Therap Adv Gastroenterol       Date:  2019-10-07       Impact factor: 4.409

5.  Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis.

Authors:  Zhaohui Bai; Mauro Bernardi; Eric M Yoshida; Hongyu Li; Xiaozhong Guo; Nahum Méndez-Sánchez; Yingying Li; Ran Wang; Jiao Deng; Xingshun Qi
Journal:  Aging (Albany NY)       Date:  2019-10-08       Impact factor: 5.682

Review 6.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

Review 7.  Lights and Shadows in Hepatic Encephalopathy Diagnosis.

Authors:  Piero Amodio; Sara Montagnese
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

Review 8.  Hepatic Encephalopathy: Diagnosis and Management.

Authors:  Lorenzo Ridola; Jessica Faccioli; Silvia Nardelli; Stefania Gioia; Oliviero Riggio
Journal:  J Transl Int Med       Date:  2020-12-31

9.  Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis: Which comes first?

Authors:  Lorenzo Ridola; Oliviero Riggio; Stefania Gioia; Silvia Nardelli
Journal:  Saudi J Gastroenterol       Date:  2020 May-Jun       Impact factor: 2.485

10.  A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy.

Authors:  Aisha Vadhariya; Hua Chen; Omar Serna; Hani Zamil; Susan M Abughosh
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.